|
James H. Cavanaugh Ph.D. has been a director since our inception. Dr. Cavanaugh has been the president of HealthCare Ventures LLC since 1988. Dr. Cavanaugh served as president of SmithKline and French Laboratories U.S. Inc. from March 1985 to February 1989 and as president of SmithKline Clinical Laboratories from 1981 to 1985. Prior thereto Dr. Cavanaugh was the president of Allergan International a specialty eye care company. Prior to his industry experience Dr. Cavanaugh was Deputy Assistant to the President for Domestic Affairs and Deputy Chief of the White House Staff. Prior thereto he served as deputy assistant secretary for health and scientific affairs in the U.S. Department of Health Education and Welfare and as special assistant to the surgeon general of the U.S. Public Health Service. Dr. Cavanaugh serves as a member of the board of directors of MedImmune Inc. Shire Pharmaceuticals Group PLC Diversa Corp. and Vicuron Pharmaceuticals (formerly Versicor Inc.). Dr. Cavanaugh also currently serves on the board of directors of the National Venture Capital Association and as trustee emeritus of the California College of Medicine. Dr. Cavanaugh holds a Ph.D. and an M.S. from the University of Iowa and a B.S. from Fairleigh Dickinson University. Dr. Cavanaugh was elected to serve on our board of directors pursuant to a stockholders? agreement between us and holders of our preferred stock. Dr. Cavanaugh currently serves as the chairman of our Nominating & Governance Committee and is a member of our Executive Committee. | 